
Garden Q&A: Is it too late to prune my hydrangeas in April?
Is it too late to prune my hydrangeas?
Answer
It's a question I'm often asked at this time of year, and as with many gardening questions, the answer depends on the type of hydrangea you have.
If you're growing Hydrangea macrophylla, the big-leaved mophead or lacecap varieties, then tread carefully. These flower on old wood, and they set their flower buds around now during mid-late spring.
If you cut back too hard in April, you risk losing this year's flowers. At this stage, it's best to simply remove any dead flower heads and tidy the plant by snipping out damaged or crossing stems. Leave the rest alone and let it bloom.
But, if you have Hydrangea paniculata or Hydrangea arborescens varieties such as the well-known Annabelle, you're still just about in time. These varieties flower on new wood, so you can prune them back hard now to encourage strong, upright growth and larger flower heads in summer.
Always use clean, sharp secateurs and aim to prune on a dry day. And remember, even if you make a mistake, hydrangeas are forgiving plants. With a bit of time and care, they'll bounce back stronger next season. That's the joy of gardening.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
Hims & Hers Q2 2025: What You Need to Know Ahead of Earnings
Hims & Hers Health (NYSE:HIMS) reports Q2 2025 earnings after U.S. markets close on Monday, August 4. Analysts expect revenue of around $552 million, up 75% YoY, and adjusted EPS near $0.15, roughly up 15% YoY. Despite the volatility, shares are up 154% YTD, pushing the forward P/E to roughly 57. Subscriber growth remains the core engine investors care about. Subscribers increased 38% in Q1, reaching 2.4 million. Weight-loss GLP-1 offerings are a swing factor, but Novo Nordisk (NYSE:NVO) ended its partnership on 23 Jun 2025, citing illegal mass compounding and deceptive marketing, which sent Hims down 30%. Analysts estimate that up to half of Hims' projected weight-loss revenue could be at risk. Investors need clarity on FDA scrutiny, formulary access, and whether compounded semaglutide margins can hold. Marketing spend, revenue per average user, and progress on the ZAVA integration will also be closely watched. Management guides FY25 revenue of $2.32.4 billion and low-teens EBITDA margins. Any uplift to those guides or clean regulatory commentary could keep momentum intact. But with valuation stretched, even a top-line beat may disappoint if churn ticks up or compliance costs bite. Q2 will test whether the telehealth disrupter can scale responsibly before regulators step in. This article first appeared on GuruFocus. Sign in to access your portfolio
Yahoo
24 minutes ago
- Yahoo
NYSE names Bryan Daniel as president of NYSE Texas
(Reuters) -The New York Stock Exchange said on Monday it has named Bryan Daniel, a former staffer of Texas Governor Greg Abbott, as the president of NYSE Texas. The move comes months after Intercontinental Exchange-owned NYSE said it would launch in Texas, as the state emerges as a financial hub and a challenger to New York. Daniel will report to Lynn Martin, president of the NYSE Group. Sign in to access your portfolio
Yahoo
24 minutes ago
- Yahoo
AI Glasses Could Replace Smartphones, Zuckerberg Says
Meta Platforms (NASDAQ:META) is pushing a post-iPhone era with AI-powered glasses, recasting the smartphone as yesterday's interface. Investors are weighing in whether Zuckerberg's personal superintelligence vision can move from manifesto to mainstream. Warning! GuruFocus has detected 5 Warning Sign with META. He says the glasses will know users deeply, understand goals and help achieve them, and the company is piling on AI talent to build standalone versions that no longer need a phone. Right now the Ray-Ban smartglasses still lean on smartphones, but the roadmap is toward independent multimodal displays. Apple is defending the iPhone's role, while rivals are racing too: Amazon bought wearable startup Bee and Sam Altman is teaming with Jony Ive on a secret AI device. The shift in tone at Meta, from past hardware misses to a more urgent, existential pitch, is meant to turn skepticism into a narrative of necessity. This article first appeared on GuruFocus. Sign in to access your portfolio